1. U.S. Food and Drug administration. Food and Drug Administration's overall risk management activities. [online] , (2015).
2. European Medicines Agency. Reflection paper on benefit-risk assessment methods in the context of the evaluation of marketing authorisation application of medicinal products for human use. [online] , (2008).
3. European Medicines Agency. Guideline on the evaluation of anticancer products in man. [online] , (2012).
4. The National Cancer Institute. Common terminology criteria for adverse events, version 3.0. [online] , (2006).
5. U.S. Food and Drug Administration. Clinical Outcome Assessment (COA): glossary of terms. [online] , (2015).